Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Could An Evolutionary Theory Explain Tissues’ Susceptibility to Cancer?

XTALKS VITALS NEWS

Researchers suggest that natural selection may have played a role in the tissue types which are more susceptible to developing cancer.

Tweetables from this article:

Tweet: "Malignant cells are living entities - it's just impossible that they are not influenced by the ecological conditions"

Share this!

September 7, 2016 | by Sarah Massey, M.Sc.

Why is it that some tissues and organs, such as the breast or lungs, are more likely to develop malignant tumors compare to others? Researchers at the Centre for Ecological and Evolutionary Research on Cancer in France, have attempted to offer an evolutionary answer to this question in an opinion article published in the journal, Trends in Cancer.

These researchers suggest that natural selection may have played a role in the tissue types which are more susceptible to developing cancer. They postulate that because tumors in larger organs represent a lesser burden on the body compared to those in smaller, critical organs, larger organs may have evolved fewer anti-cancer mechanisms.

“The organs that are the most important to keeping you alive and capable of reproduction, such as the heart, brain, or uterus, may enjoy a better protection against cancer, all other things being equal,” said Frédéric Thomas, an evolutionary biologist at the Center for Ecological and Evolutionary Cancer Research in France. “We are not saying that this is the main factor to explain the different susceptibility of organs to cancer, but it is a factor that contributes with others.”

While many have pointed to external cancer risk factors, such as smoking, and internal risk factors, such as rates of cell division, as an explanation for differing rates of cancer development among organ types, these risk factors are not always sufficient. To supplement our current understanding of oncology, Thomas and his colleagues have put forth an evolutionary theory of cancer susceptibility.

“, whereas small and important organs like the pancreas could be easily compromised with only a few tumors inside,” said Thomas. By this logic, the researchers say that organs such as the pancreas could have better anti-cancer mechanisms, compared to paired organs such as the kidneys.



In addition to their evolutionary theory, Thomas and his colleagues are urging oncologists to consider the environmental conditions – such as acidity, oxygen availability and water level – of organs which could make them a more favorable location for cancer cells to grow and proliferate. “Malignant cells are living entities - it's just impossible that they are not influenced by the ecological conditions,” said Thomas. “It clearly means that certain organs are more favorable than others to malignant perturbation.”

Thomas and his team are now working on a long-term experiment using mice to measure the incidence of cancer development in certain organs. This, along with other research, will be used to test the researchers’ evolutionary hypothesis.

“A complete analysis requires that we take into account all the possible confounding factors,” said Thomas. “We cannot just look at existing statistics on cancer and the size of the organs and make a correlation to see if it works or not. It's a novel hypothesis that deserves to be explored.”


Keywords: Cancer, Evolution, Tissues


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News


PTC to Acquire Marathon’s Recently Approved Duchenne Muscular Dystrophy Drug

March 17, 2017 - Amid a drug pricing controversy, PTC Therapeutics has agreed to buy Marathon Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug, Emflaza.

Featured In: Pharmaceutical News


Memphis Meats Produces World’s First Poultry from Animal Cells

March 17, 2017 - Silicon Valley-based food manufacturing company, Memphis Meats, has produced the world’s first “clean poultry” by growing chicken and duck cells outside the animals.

Featured In: Food News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.